+Search query
-Structure paper
Title | A novel irreversible FLT3 inhibitor, FF-10101, shows excellent efficacy against AML cells withFLT3mutations. |
---|---|
Journal, issue, pages | Blood, Vol. 131, Page 426-438, Year 2018 |
Publish date | Jan 19, 2017 (structure data deposition date) |
Authors | Yamaura, T. / Nakatani, T. / Uda, K. / Ogura, H. / Shin, W. / Kurokawa, N. / Saito, K. / Fujikawa, N. / Date, T. / Takasaki, M. ...Yamaura, T. / Nakatani, T. / Uda, K. / Ogura, H. / Shin, W. / Kurokawa, N. / Saito, K. / Fujikawa, N. / Date, T. / Takasaki, M. / Terada, D. / Hirai, A. / Akashi, A. / Chen, F. / Adachi, Y. / Ishikawa, Y. / Hayakawa, F. / Hagiwara, S. / Naoe, T. / Kiyoi, H. |
External links | Blood / PubMed:29187377 |
Methods | X-ray diffraction |
Resolution | 2.401 Å |
Structure data | PDB-5x02: |
Chemicals | ChemComp-F6M: ChemComp-SO4: ChemComp-HOH: |
Source |
|
Keywords | TRANSFERASE/TRANSFERASE INIHIBITOR / tyrosine kinase / transferase / irreversible inhibitor complex / kinase catalytic domain / TRANSFERASE-TRANSFERASE INIHIBITOR complex |